KY-2

N/A

Report date: 2025/06/24 15:24:57
NME

Base Information

Drug NameKY-2
Drug Alias NameKY-2
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRNA helicases inhibitorsDEAH-Box Helicase 33 modulators
TargetsRNA helicasesDEAH-Box Helicase 33
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShenzhen KeYe Life Technologies Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShenzhen KeYe Life Technologies Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A